Scienture launches Rezenopy, a 10 mg naloxone nasal spray for opioid overdoses, fulfilling initial U.S. wholesale orders.

Statements (2)

1. ● Neutral

   SCIENTURE entered into an agreement with a distribution partner to expand commercial reach of REZENOPY• to addiction treatment centers.

   markets.businessinsider.comSep 22, 2026 12:15 UTC
2. ● Neutral

   Scienture launches Rezenopy, a 10 mg naloxone nasal spray for opioid overdoses, fulfilling initial U.S. wholesale orders.

   benzinga.comAug 12, 2026 11:46 UTC